New Lifestyle Drugs and Somatoform Disorders in Dermatology

    December 2007 in “ Journal of The European Academy of Dermatology and Venereology ”
    W. Harth, Kurt Seikowski, B Hermes, Uwe Gieler
    Studysummary This paper discusses the use of lifestyle drugs by individuals without medical conditions to enhance appearance, highlighting that such usage may worsen emotional disorders and suggests these should be treated with psychotherapy or psychopharmacotherapy.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 6

    1. The Importance of Dual 5α-Reductase Inhibition in the Treatment of Male Pattern Hair Loss: Results of a Randomized Placebo-Controlled Study of Dutasteride Versus Finasteride Journal of The American Academy of Dermatology · 2006
    2. Finasteride in the Treatment of Androgenetic Alopecia Expert Opinion on Pharmacotherapy · 2004
    3. The Presence of Trichodynia in Patients With Telogen Effluvium and Androgenetic Alopecia International Journal of Dermatology · 2003
    4. Chronic Prostatitis And Chronic Pelvic Pain In Men: Aetiology, Diagnosis And Management Journal of the European Academy of Dermatology and Venereology · 2002
    5. The Dorian Gray Syndrome: Psychodynamic Need for Hair Growth Restorers and Other Fountains of Youth International Journal of Clinical Pharmacology and Therapeutics · 2001
    6. The Psychological Effects of Androgenetic Alopecia in Men Journal of The American Academy of Dermatology · 1992